NEUROPATHY;PERIPHERAL
Clinical trials for NEUROPATHY;PERIPHERAL explained in plain language.
Never miss a new study
Get alerted when new NEUROPATHY;PERIPHERAL trials appear
Sign up with your email to follow new studies for NEUROPATHY;PERIPHERAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo tackles nerve pain in rare blood conditions
Disease control OngoingThis study tests whether adding acalabrutinib to standard rituximab therapy is safe and effective for people with nerve damage (neuropathy) linked to two blood conditions: IgM MGUS or Waldenstrom macroglobulinemia. The 12 participants receive both drugs to see if the combination …
Matched conditions: NEUROPATHY;PERIPHERAL
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
Soundwaves may soothe chemo nerve damage
Symptom relief OngoingThis study tests a device called SensoniQ® that uses low-frequency soundwaves to prevent or reduce nerve pain caused by chemotherapy in people with gynecologic cancer. About 80 participants will either receive the treatment while starting chemo or after having persistent nerve pa…
Matched conditions: NEUROPATHY;PERIPHERAL
Phase: NA • Sponsor: Augusta University • Aim: Symptom relief
Last updated May 17, 2026 05:34 UTC
-
Zapping nerve pain: new hope for chemo survivors?
Symptom relief OngoingThis study explores whether a technique called neuromodulation can reduce pain caused by chemotherapy. Researchers will test 24 adults who have nerve pain in their legs from certain cancer drugs. The main goal is to see if the treatment is safe and if it improves symptoms.
Matched conditions: NEUROPATHY;PERIPHERAL
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC